Epileptic Seizures in Multiple Sclerosis May Suggest Shared Pathology

Epileptic Seizures in Multiple Sclerosis May Suggest Shared Pathology

Patients with multiple sclerosis (MS) who experience seizures are more likely to be younger at the age of MS onset than patients with MS who do not have seizures, according to a study reported in Neurological Sciences by the Epilepsy Study Group of the Italian Neurological Society. The disease course also tended to be slightly more severe in patients with seizures.1

An overlap between MS and epileptic seizures has been observed in previous studies, although the significance of this is not well understood.2-7 The most common condition to show a higher incidence and prevalence in MS is epilepsy, estimated in 1 meta-analysis at 2.28% and 3.09%, respectively, compared with a frequency of <1% in the general population.8,9

The authors of the current meta-analysis, led by Sara Gasparini, MD, from the Magna Graecia University of Catanzaro in Italy, selected 9 studies conducted from 1996 to 2014 from a total of 668 articles available. Of those, 4 studies showed a younger age at onset of MS by a mean difference of 5.42 (95% CI, −7.19 to −3.66; P <.001).10-13

Dr Gasparini and colleagues found this pattern to be consistent with previous studies indicating a potentially more aggressive inflammatory process involved in early-onset MS, which may have a focus in the cerebral cortex.14,15 The presence of plaques in this region may play a role in the development of seizure activity.

Two studies pointed to an association between the presence of cortical lesions and seizures, although differences in the imaging techniques used did not allow for comparison between them.16,18 The first reported that a greater proportion of patients with MS with seizures had cortical lesions compared with patients with MS without seizures (84% vs 43%; P <.001), and that both the quantity and size of the lesions was larger in the MS-with-seizures group.18 The second study also found a higher mean number of lesions in patients with MS who had seizures.16

Another feature that was prominent in 5 of the 9 studies evaluated was a trend toward higher Expanded Disability Status Scale scores among patients with MS and epilepsy, although the mean difference of 0.45 was not statistically significant (95% CI, −0.01 to 0.91; P =.054).10-12,16,17 In addition, the meta-analysis did not reveal any relevant trends in sex distribution or clinical type of MS associated with the expression of seizures.

The authors were unable to draw any firm conclusions as to the potential causality of epilepsy in MS, citing suboptimal study data. They suggested that this comorbidity may be associated with poorer outcomes, as measured by Expanded Disability Status Scale scores, and that earlier onset of MS may increase the risk of developing seizures, but larger prospective studies will be necessary to support these findings.

References

  1. Gasparini S, Ferlazzo E, Ascholi M, et al. Risk factors for unprovoked epileptic seizures in multiple sclerosis: a systematic review and meta-analysis [published online January 4, 2017]. Neurol Sci. doi: 10.1007/s10072-016-2803-7
  2. Drake WE Jr, Macrae D. Epilepsy in multiple sclerosisNeurology. 1961;11:810-816.
  3. Kinnunen E, Wikström J. Prevalence and prognosis of epilepsy in patients with multiple sclerosisEpilepsia. 1986;27:729-733. doi: 10.1111/j.1528-1157.1986.tb03602.
  4. Ghezzi A, Montanini R, Basso PF, et al. Epilepsy in multiple sclerosisEur Neurol. 1990;30:218-223.
  5. Nyquist PA, Cascino GD, Rodriguez M. Seizures in patients with multiple sclerosis seen at Mayo Clinic, Rochester, Minn, 1990–1998Mayo Clin Proc. 2001;76:983-986. doi; 10.4065/76.10.983
  6. Nicoletti A, Sofia V, Biondi R, Lo. Epilepsy and multiple sclerosis in Sicily: a population-based studyEpilepsia. 2003;44:1445-1448. doi: 10.1046/j.1528-1157.2003.09203.x
  7. Striano P, Orefice G, Brescia Morra V. Epileptic seizures in multiple sclerosis: clinical and EEG correlationsNeurol Sci. 2003;24:322-328. doi: 10.1007/s10072-003-0183-2
  8. Krökki O, Bloigu R, Ansakorpi H, et al. Neurological comorbidity and survival in multiple sclerosisMult Scler Relat Disord. 2014;3:72-77. doi: 10.1016/j.msard.2013.06.006
  9. Marrie RA, Reider N, Cohen J, et al. A systematic review of the incidence and prevalence of sleep disorders and seizure disorders in multiple sclerosisMult Scler. 2015;21:342-349. doi: 10.1177/1352458514564486.
  10. Sokic DV, Stojsavljevic N, Drulovic J, et al. Seizures in multiple sclerosisEpilepsia. 2001; 42:72-79. doi: 10.1046/j.1528-1157.2001.48699.x
  11. Durmus H, Kurtuncu M, Tuzun E, et al. Comparative clinical characteristics of early- and adult-onset multiple sclerosis patients with seizuresActa Neurol Belg. 2013;113:421-426. doi: 10.1007/s13760-013-0210-x
  12. Uribe-San-Martın R, Ciampi-Dıaz E, Suarez-Hernandez F, et al. Prevalence of epilepsy in a cohort of patients with multiple sclerosisSeizure. 2014;23:81-83. doi: 10.1016/j.seizure.2013.09.008
  13. Catenoix H, Marignier R, Ritleng C, et al. Multiple sclerosis and epileptic seizuresMult Scler. 2011;17:96-102. doi: 10.1177/1352458510382246
  14. Renoux C, Vukusic S, Mikaeloff Y, et al; Adult Neurology Departments KIDMUS Study Group. Natural history of multiple sclerosis with childhood onsetN Engl J Med. 2007;356:2603-2613. doi: 10.1056/NEJMoa067597
  15. Magliozzi R, Howell O, Vora A, et al. Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathologyBrain. 2007;130:1089-1104. doi: 10.1093/brain/awm038
  16. Martınez-Lapiscina EH, Ayuso T, Lacruz F, et al. Cortico-juxtacortical involvement increases risk of epileptic seizures in multiple sclerosisActa Neurol Scand. 2013;128:24-31. doi: 10.1111/ane.12064
  17. Shaygannejad V, Ashtari F, Zare M, et al. Seizure characteristics in multiple sclerosis patientsJ Res Med Sci. 2013;18:S74-S77.
  18. Calabrese M, Grossi P, Favaretto A, et al. Cortical pathology in multiple sclerosis patients with epilepsy: a 3 year longitudinal studyJ Neurol Neurosurg Psychiatry. 2012;83:49-54. doi: 10.1136/jnnp-2011-300414

By Linda Peckel

Neurology Advisor

CMSC Disclaimer

The industry news information and articles are for informational purposes only, and are not intended to represent any trends, partnerships, commitments, or research of the Consortium of MS Centers or any of it's members in any way whatsoever, nor should any party be libel in any way to the reader or to any other person, firm or corporation reading this industry news section. Although the CMSC site includes links providing direct access to other Internet sites, CMSC takes no responsibility for the content or information contained on those other sites, and does not exert any editorial or other control over those other sites. CMSC is providing information and services on the Internet as a benefit and service in furtherance of CMSC's nonprofit and tax-exempt status. CMSC makes no representations about the suitability of this information and these services for any purpose.

Elizabeth Porco

Comments are closed.

CMSC provides leadership in clinical research and education; develops vehicles to share information and knowledge among members; disseminates information to the health care community and to persons affected by MS.

Contact Us
Contact Us
I have a question about
First
Last

Feel Free To contact Us
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nam molestie, tellus id pellen tesque feugiat, sem sem cursus orci, a placerat ante ante nec massa. consectetuer adipiscing elit.

+1-222-333-4444

New York, NY 10123 USA

Mon - Sat 9:00 AM